Hong Kong Pharma Digital Technology Statistics
Share Statistics
Hong Kong Pharma Digital Technology has 12.34M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 12.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 753 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 125.71K, so 1.14% of the outstanding
shares have been sold short.
| Short Interest | 125.71K |
| Short % of Shares Out | 1.14% |
| Short % of Float | 2.64% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Hong Kong Pharma Digital Technology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.46,
with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.46 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | -4.33 |
| Interest Coverage | 19.43 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $878,334.95 |
| Profits Per Employee | $69,985.11 |
| Employee Count | 19 |
| Asset Turnover | 1.93 |
| Inventory Turnover | 14.07 |
Taxes
| Income Tax | 196.25K |
| Effective Tax Rate | 12.86% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 5.26, so Hong Kong Pharma Digital Technology's
price volatility has been higher than the market average.
| Beta | 5.26 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.1 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 50.95 |
| Average Volume (20 Days) | 1,014,060 |
Income Statement
In the last 12 months, Hong Kong Pharma Digital Technology had revenue of 16.69M
and earned 1.33M
in profits. Earnings per share was 0.
| Revenue | 16.69M |
| Gross Profit | 3.56M |
| Operating Income | 1.61M |
| Net Income | 1.33M |
| EBITDA | 2.53M |
| EBIT | 1.61M |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 619.58K in cash and 2.09M in
debt, giving a net cash position of -1.47M.
| Cash & Cash Equivalents | 619.58K |
| Total Debt | 2.09M |
| Net Cash | -1.47M |
| Retained Earnings | 1.53M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -394.33K
and capital expenditures -88.02K, giving a free cash flow of -482.35K.
| Operating Cash Flow | -394.33K |
| Capital Expenditures | -88.02K |
| Free Cash Flow | -482.35K |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 21.32%, with operating and profit margins of 9.64% and 7.97%.
| Gross Margin | 21.32% |
| Operating Margin | 9.64% |
| Pretax Margin | 9.14% |
| Profit Margin | 7.97% |
| EBITDA Margin | 15.19% |
| EBIT Margin | 9.64% |
| FCF Margin | -2.89% |
